These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The effects of antacids on the absorption of orally administered pentobarbital in the rat. Hurwitz A; Sheehan MB J Pharmacol Exp Ther; 1971 Oct; 179(1):124-31. PubMed ID: 5096563 [No Abstract] [Full Text] [Related]
26. [Iron in the dialyzed chronic renal insufficiency patient: an aspect that is too frequently neglected]. Canaud B; Kessler M; Chanliau J Nephrol Ther; 2006 Nov; 2 Suppl 5():S289. PubMed ID: 17373272 [No Abstract] [Full Text] [Related]
27. Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis. Robertson JA; Salusky IB; Goodman WG; Norris KC; Coburn JW Ann Intern Med; 1989 Jul; 111(2):179-81. PubMed ID: 2742249 [No Abstract] [Full Text] [Related]
28. Iron regulation. Himmelfarb J J Am Soc Nephrol; 2007 Feb; 18(2):379-81. PubMed ID: 17229918 [No Abstract] [Full Text] [Related]
29. Effect of coadministration of aluminum and magnesium hydroxides on absorption of anticoagulants in man. Ambre JJ; Fischer LJ Clin Pharmacol Ther; 1973; 14(2):231-7. PubMed ID: 4121122 [No Abstract] [Full Text] [Related]
30. Investigation of the possible influence of the absorption of vinpocetine with concomitant application of magnesium-aluminium-hydroxide gel. Lohmann A; Grobara P; Dingler E Arzneimittelforschung; 1991 Nov; 41(11):1164-7. PubMed ID: 1810262 [TBL] [Abstract][Full Text] [Related]
31. Aluminum absorption in the rat everted gut sac. Feinroth M; Feinroth MV; Berlyne GM Miner Electrolyte Metab; 1982 Jul; 8(1):29-35. PubMed ID: 7167130 [TBL] [Abstract][Full Text] [Related]
33. Enhanced pseudoephedrine absorption by concurrent administration of aluminum hydroxide gel in humans. Lucarotti RL; Colaizzi JL; Barry H; Poust RI J Pharm Sci; 1972 Jun; 61(6):903-5. PubMed ID: 5046107 [No Abstract] [Full Text] [Related]
34. Aluminium hydroxide gels and intestinal phosphorus absorption. Bingham S; Rose GA J Hum Nutr; 1977 Feb; 31(1):5-10. PubMed ID: 874318 [No Abstract] [Full Text] [Related]
35. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency]. Sárszegi Z; Jobst K; Nagy J Orv Hetil; 2000 Aug; 141(35):1915-7. PubMed ID: 11019592 [TBL] [Abstract][Full Text] [Related]
36. Zinc tolerance test in uremia. Effect of ferrous sulfate and aluminum hydroxide. Abu-Hamdan DK; Mahajan SK; Migdal SD; Prasad AS; McDonald FD Ann Intern Med; 1986 Jan; 104(1):50-2. PubMed ID: 3940504 [TBL] [Abstract][Full Text] [Related]
37. [The role of aluminum-induced inhibition of the intestinal absorption of calcium in the pathogenesis of aluminum osteopathy]. Blahos J; Care AD; Abbas M; Aaron J; Porsova I Ann Endocrinol (Paris); 1989; 50(1):40-3. PubMed ID: 2729880 [TBL] [Abstract][Full Text] [Related]
38. Effect of aluminum hydroxide gel on quinidine gluconate absorption. Mauro VF; Mauro LS; Fraker TD; Temesy-Armos PN; Somani P DICP; 1990 Mar; 24(3):252-4. PubMed ID: 2316233 [TBL] [Abstract][Full Text] [Related]
39. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload. von Bonsdorff M; Sipilä R; Pitkänen E Scand J Urol Nephrol Suppl; 1990; 131():49-54. PubMed ID: 2075470 [TBL] [Abstract][Full Text] [Related]
40. Rational nursing care in chronic renal disease. Lavandero R; Davis V Am J Nurs; 1979 Nov; 79(11):1938, 1941. PubMed ID: 258954 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]